Boiron SA (BOI) - Financial and Strategic SWOT Analysis Review

July 2021 | 39 pages | ID: BCE91DE6829EN
GlobalData

Abstracts

Boiron SA (BOI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Boiron SA (Boiron) is a pharmaceutical company that develops, manufactures and commercializes homeopathic medicines. The company manufactures products through vegetable, animal, mineral or chemical origins. Its product portfolio comprises Camilia, Arnigel, Oscillococcinum, HomeovoX, Sedatif PC, Coryzalia, Arnicalme, Homeoptic, Stodaline and Stodal. Boiron’s products are used for the treatment of fever, chills, cold, headaches, aches, coughs, muscle fatigue, bruising, contusions and others. The company has operational presence in Western Europe, Central Eastern and Europe and North America. It also manages production facilities in Montrichard (Loir-et-Cher), Messimy (Rhone), Sainte-Foy-Les-Lyon and Montevrain (Seine-et-Marne). Boiron is headquartered in Messimy, France.

Boiron SA Key Recent Developments

Sep 09,2020: Boiron: 2020 half-year results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Boiron SA - Key Facts
Boiron SA - Key Employees
Boiron SA - Key Employee Biographies
Boiron SA - Major Products and Services
Boiron SA - History
Boiron SA - Company Statement
Boiron SA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Boiron SA - Business Description
Business Segment: Non-Proprietary Homeopathic Medicines
Overview
Performance
Business Segment: OTC Specialties
Overview
Performance
Business Segment: Other
Overview
Performance
Geographical Segment: Europe excluding France
Performance
Geographical Segment: France
Performance
Geographical Segment: North America
Performance
Geographical Segment: Other Countries
Performance
R&D Overview
Boiron SA - SWOT Analysis
SWOT Analysis - Overview
Boiron SA - Strengths
Boiron SA - Weaknesses
Boiron SA - Opportunities
Boiron SA - Threats
Boiron SA - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Boiron SA, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Boiron SA, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Boiron SA, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Sep 09, 2020: Boiron: 2020 half-year results

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Boiron SA, Key Facts
Boiron SA, Key Employees
Boiron SA, Key Employee Biographies
Boiron SA, Major Products and Services
Boiron SA, History
Boiron SA, Subsidiaries
Boiron SA, Key Competitors
Boiron SA, Ratios based on current share price
Boiron SA, Annual Ratios
Boiron SA, Annual Ratios (Cont...1)
Boiron SA, Annual Ratios (Cont...2)
Boiron SA, Interim Ratios
Boiron SA, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Boiron SA, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Boiron SA, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Boiron SA, Performance Chart (2016 - 2020)
Boiron SA, Ratio Charts
Boiron SA, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Boiron SA, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021